Dyne Therapeutics, Inc. (DYN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Group 1 - The presentation is part of the Morgan Stanley Global Healthcare Conference, highlighting the participation of Dyne Therapeutics' leadership team [1] - Michael Ulz serves as the equity analyst and introduces the team, including John Cox, the President and CEO, and Erick Lucera, the CFO [1] Group 2 - The conference aims to provide insights for those unfamiliar with Dyne Therapeutics, with John Cox expected to deliver introductory comments [2]